Overzicht van nieuwe geneesmiddelen (ATC-codes) in 2021 met de vergoeding per jaar
- Raming voor de totale Zvw-populatie
| Introductiejaar | ATC-code | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| 2021 | A16AX16 Givosiran | 288.612 | 2.218.286 | 1.975.462 |
| B02BX08 Avatrombopag | 10.693 | 245.207 | 1.083.460 | |
| J05AJ04 Cabotegravir | 46.128 | 1.969.628 | 4.449.021 | |
| J07BK03 Zoster gezuiverd antigeen | 127.841 | 1.101.317 | 2.170.106 | |
| L04AE03 Immunosuppressiva | 1.364.136 | 3.412.209 | 3.913.074 | |
| M05BX06 Romosozumab | 778.317 | 2.852.013 | 5.628.701 | |
| M09AX03 Ataluren | 9.205 | 4.811.616 | 4.934.175 | |
| N02CD01 Erenumab | 562.853 | 7.030.763 | 8.871.035 | |
| N02CD02 Galcanezumab | 1.029.076 | 6.643.213 | 8.396.729 | |
| N02CD03 Fremanezumab | 352.565 | 5.351.650 | 8.977.162 | |
| R03AK14 Indacaterol met mometason | 9.857 | 28.721 | 37.737 | |
| R03AL11 Formoterol met glycopyrroniumbromide en budesonide | 77.430 | 366.573 | 851.893 | |
| V03AE10 Natriumzirconiumcyclosilicaat | 102.990 | 301.267 | 548.374 | |
| Totaal | 4.759.703 | 36.332.462 | 51.836.930 |